Host explores Ozempic's real results and hidden risks, covering STEP1 trial data, weight regain after stopping, and Oxford research on rebound weight gain. This episode examines why semaglutide works, why most users quit within two years, and what listeners should know before starting GLP-1 weight loss treatment.

Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Liquid Studios. Innehållet i podden är skapat av Liquid Studios och inte av, eller tillsammans med, Poddtoppen.